{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:54:50Z","timestamp":1793199290519,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.intimp.2022.109105","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T19:15:27Z","timestamp":1659467727000},"page":"109105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["High-throughput DNA methylation analysis in ITP confirms NOTCH1 hypermethylation through the Th1 and Th2 cell differentiation pathways"],"prefix":"10.1016","volume":"111","author":[{"given":"Shu-yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-ting","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hui","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-ning","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2022.109105_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.intimp.2022.109105_b0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41568-019-0109-9","article-title":"Epigenetic therapy in immune-oncology","volume":"19","author":"Jones","year":"2019","journal-title":"Nat. Rev. Cancer."},{"issue":"6","key":"10.1016\/j.intimp.2022.109105_b0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","article-title":"DNA methylation-based biomarkers and the epigenetic clock theory of ageing","volume":"19","author":"Horvath","year":"2018","journal-title":"Nat. Rev. Genet."},{"issue":"35","key":"10.1016\/j.intimp.2022.109105_b0020","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1038\/sj.onc.1205599","article-title":"Gene silencing in mammalian cells and the spread of DNA methylation","volume":"21","author":"Turker","year":"2002","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.intimp.2022.109105_b0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/EBC20190030","article-title":"Enhancer DNA methylation: implications for gene regulation","volume":"63","author":"Angeloni","year":"2019","journal-title":"Essays. Biochem."},{"issue":"11","key":"10.1016\/j.intimp.2022.109105_b0030","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","article-title":"Navigating the DNA methylation landscape of cancer","volume":"37","author":"Nishiyama","year":"2021","journal-title":"Trends Genet. : TIG."},{"key":"10.1016\/j.intimp.2022.109105_b0035","article-title":"Insights Into the Role of DNA Methylation in Immune Cell Development and Autoimmune Disease","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109105_b0040","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of immune thrombocytopenia","volume":"16","author":"Audia","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"13","key":"10.1016\/j.intimp.2022.109105_b0045","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.7150\/ijbs.33779","article-title":"Disrupted balance of CD4+ T-cell subsets in bone marrow of patients with primary immune thrombocytopenia","volume":"15","author":"Wang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2022.109105_b0050","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/jcp.27180","article-title":"The pathogenesis of thyroid autoimmune diseases: New T lymphocytes - Cytokines circuits beyond the Th1-Th2 paradigm","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2022.109105_b0055","doi-asserted-by":"crossref","first-page":"5697149","DOI":"10.1155\/2018\/5697149","article-title":"Circulating Th1, Th2, Th9, Th17, Th22, and Treg Levels in Aortic Dissection Patients","volume":"2018","author":"Ye","year":"2018","journal-title":"Mediators. Inflamm."},{"key":"10.1016\/j.intimp.2022.109105_b0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.intimp.2016.05.002","article-title":"RhIL-11 treatment normalized Th1\/Th2 and T-bet\/GATA-3 imbalance in in human immune thrombocytopenic purpura (ITP)","volume":"38","author":"Lin","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109105_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-007-2111-3","article-title":"Inflammatory bowel disease, past, present and future: lessons from animal models","volume":"43","author":"Mizoguchi","year":"2008","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.intimp.2022.109105_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102315","article-title":"Epigenetic perspectives on systemic autoimmune disease","volume":"104","author":"Karagianni","year":"2019","journal-title":"J. Autoimmun."},{"issue":"12","key":"10.1016\/j.intimp.2022.109105_b0075","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1172\/JCI137712","article-title":"Maintenance DNA methylation is essential for regulatory T cell development and stability of suppressive function","volume":"130","author":"Aelmin","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.intimp.2022.109105_b0080","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.humimm.2014.09.018","article-title":"Foxp3 methylation status in children with primary immune thrombocytopenia","volume":"75","author":"Chen","year":"2014","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.intimp.2022.109105_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.630693","article-title":"Low-Dose Decitabine Inhibits Cytotoxic T Lymphocytes-Mediated Platelet Destruction via Modulating PD-1 Methylation in Immune Thrombocytopenia","volume":"12","author":"Han","year":"2021","journal-title":"Front. Immunol."},{"issue":"12\u201313","key":"10.1016\/j.intimp.2022.109105_b0090","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.molimm.2011.04.012","article-title":"Increased expressions of DNA methyltransferases contribute to CD70 promoter hypomethylation and over expression of CD70 in ITP","volume":"48","author":"Ma","year":"2011","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2022.109105_b0095","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41584-020-0470-9","article-title":"Clinical value of DNA methylation markers in autoimmune rheumatic diseases","volume":"16","author":"Ballestar","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109105_b0100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41571-018-0004-4","article-title":"Analysis of DNA methylation in cancer: location revisited","volume":"15","author":"Koch","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2022.109105_b0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00277-005-0008-x","article-title":"Decitabine: a historical review of the development of an epigenetic drug","volume":"84","author":"de Vos","year":"2005","journal-title":"Ann. Hematol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109105_b0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/cancers10060158","article-title":"Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML","volume":"10","author":"Kubasch","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.intimp.2022.109105_b0115","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/ph5080875","article-title":"A Perspective on the Comparative Antileukemic Activity of 5-Aza-2'-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)","volume":"5","author":"Momparler","year":"2012","journal-title":"Pharmaceuticals (Basel)."},{"issue":"5","key":"10.1016\/j.intimp.2022.109105_b0120","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1160\/TH14-04-0342","article-title":"Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia","volume":"113","author":"Zhou","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.intimp.2022.109105_b0125","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/ajh.25646","article-title":"A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia","volume":"94","author":"Zhou","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"21","key":"10.1016\/j.intimp.2022.109105_b0130","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","article-title":"Clinical updates in adult immune thrombocytopenia","volume":"129","author":"Lambert","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.intimp.2022.109105_b0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/gb-2012-13-10-r92","article-title":"Gel-free multiplexed reduced representation bisulfite sequencing for large-scale DNA methylation profiling","volume":"13","author":"Boyle","year":"2012","journal-title":"Genome. Biol."},{"key":"10.1016\/j.intimp.2022.109105_b0140","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1471-2105-10-232","article-title":"BSMAP: whole genome bisulfite sequence MAPping program","volume":"10","author":"Xi","year":"2009","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.intimp.2022.109105_b0145","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fimmu.2018.00880","article-title":"Emerging Concepts in Immune Thrombocytopenia","volume":"9","author":"Swinkels","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109105_b0150","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1042\/EBC20190031","article-title":"DNA methylation at the crossroads of gene and environment interactions","volume":"63","author":"Law","year":"2019","journal-title":"Essays. Biochem."},{"key":"10.1016\/j.intimp.2022.109105_b0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2016.01.011","article-title":"DNA methylation perspectives in the pathogenesis of autoimmune diseases","volume":"164","author":"Sun","year":"2016","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109105_b0160","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3324\/haematol.2018.204917","article-title":"Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated","volume":"104","author":"Mart\u00ednez-Calle","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.intimp.2022.109105_b0165","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1152\/physrev.00005.2017","article-title":"Notch Signaling in Development, Tissue Homeostasis, and Disease","volume":"97","author":"Siebel","year":"2017","journal-title":"Physiol Rev."},{"issue":"5804","key":"10.1016\/j.intimp.2022.109105_b0170","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1126\/science.1134042","article-title":"Notch, a universal arbiter of cell fate decisions","volume":"314","author":"Ehebauer","year":"2006","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.intimp.2022.109105_b0175","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2016-09-692582","article-title":"The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia","volume":"129","author":"Sanchez-Martin","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2022.109105_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-017-0664-4","article-title":"Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-\u03b21","volume":"37","author":"Yang","year":"2018","journal-title":"J. Exp. Clin. Cancer. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109105_b0185","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1038\/s41467-021-22787-9","article-title":"Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures","volume":"12","author":"Franciosa","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2022.109105_b0190","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1038\/s41467-020-18860-4","article-title":"Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1","volume":"11","author":"Jiang","year":"2020","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2022.109105_b0195","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/s41423-019-0318-x","article-title":"Jagged1-mediated myeloid Notch1 signaling activates HSF1\/Snail and controls NLRP3 inflammasome activation in liver inflammatory injury","volume":"17","author":"Jin","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109105_b0200","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-017-01741-8","article-title":"NOTCH1 is a mechanosensor in adult arteries","volume":"8","author":"Mack","year":"2017","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.intimp.2022.109105_b0205","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1021\/acs.nanolett.0c03279","article-title":"Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-\u03baB and Notch1 Pathways","volume":"20","author":"An","year":"2020","journal-title":"Nano. Lett."},{"issue":"22","key":"10.1016\/j.intimp.2022.109105_b0210","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1089\/scd.2017.0078","article-title":"Impaired Function of Bone Marrow Mesenchymal Stem Cells from Immune Thrombocytopenia Patients in Inducing Regulatory Dendritic Cell Differentiation Through the Notch-1\/Jagged-1 Signaling Pathway","volume":"26","author":"Xu","year":"2017","journal-title":"Stem. Cells. Dev."},{"issue":"2","key":"10.1016\/j.intimp.2022.109105_b0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/labinvest.2014.142","article-title":"Inactivation of Notch signaling reverses the Th17\/Treg imbalance in cells from patients with immune thrombocytopenia","volume":"95","author":"Yu","year":"2015","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.intimp.2022.109105_b0220","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/cei.13471","article-title":"Hypomethylation of Notch1 DNA is associated with the occurrence of uveitis","volume":"201","author":"Wei","year":"2020","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109105_b0225","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nri1998","article-title":"Notch signalling during peripheral T-cell activation and differentiation","volume":"7","author":"Osborne","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2022.109105_b0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.imlet.2019.01.003","article-title":"Notch signaling induces lymphoproliferation, T helper cell activation and Th1\/Th2 differentiation in leprosy","volume":"207","author":"Dua","year":"2019","journal-title":"Immunol. Lett."},{"issue":"11","key":"10.1016\/j.intimp.2022.109105_b0235","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1084\/jem.20161791","article-title":"Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure","volume":"214","author":"Nevers","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2022.109105_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120597","article-title":"Polymeric nanoparticle vaccines to combat emerging and pandemic threats","volume":"268","author":"Wibowo","year":"2021","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.intimp.2022.109105_b0245","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1073\/pnas.0307743100","article-title":"Kinetic analysis of genomewide gene expression reveals molecule circuitries that control T cell activation and Th1\/2 differentiation","volume":"101","author":"Lu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.intimp.2022.109105_b0250","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4049\/jimmunol.166.1.531","article-title":"Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines","volume":"166","author":"Pricop","year":"2001","journal-title":"J. Immunol."},{"issue":"5 Suppl","key":"10.1016\/j.intimp.2022.109105_b0255","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/pbc.20981","article-title":"Gene expression profile of idiopathic thrombocytopenic purpura (ITP)","volume":"47","author":"Sood","year":"2006","journal-title":"Pediatr. Blood. Cancer."},{"issue":"2","key":"10.1016\/j.intimp.2022.109105_b0260","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.thromres.2013.04.025","article-title":"Involvement of levels of Toll like receptor-4 in monocytes, CD4+ T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura","volume":"132","author":"Liu","year":"2013","journal-title":"Thromb, Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.109105_b0265","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/cei.12279","article-title":"Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP)","volume":"176","author":"Talaat","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2022.109105_b0270","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3389\/fimmu.2019.00451","article-title":"High-Dose Dexamethasone Alters the Increase in Interleukin-16 Level in Adult Immune Thrombocytopenia","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109105_b0275","first-page":"914","article-title":"Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura","volume":"90","author":"Wang","year":"2005","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.intimp.2022.109105_b0280","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1600-0609.2003.00138.x","article-title":"High Th1\/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura","volume":"71","author":"Ogawara","year":"2003","journal-title":"Eur. J. Haematol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109105_b0285","first-page":"337","article-title":"The effect of decitabine on megakaryocyte maturation and platelet release","volume":"106","author":"Wang","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.intimp.2022.109105_b0290","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.semcancer.2020.05.010","article-title":"DNMT1: A key drug target in triple-negative breast cancer","volume":"72","author":"Wong","year":"2021","journal-title":"Semin. cancer biol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109105_b0295","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood-2009-03-210393","article-title":"Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting","volume":"115","author":"Sanchez-Abarca","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.intimp.2022.109105_b0300","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.2020008477","article-title":"Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia","volume":"138","author":"Han","year":"2021","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.intimp.2022.109105_b0305","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood.2021012108","article-title":"decitabine revives Treg function in ITP","volume":"138","author":"Kapur","year":"2021","journal-title":"Blood"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:46:47Z","timestamp":1761587207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922005896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":61,"alternative-id":["S1567576922005896"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109105","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-throughput DNA methylation analysis in ITP confirms NOTCH1 hypermethylation through the Th1 and Th2 cell differentiation pathways","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109105"}}